Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PCORI To Fund Development Of Data Networks For CER, Clinical Development

This article was originally published in The Pink Sheet Daily

Executive Summary

Patient-Centered Outcomes Research Institute plans up to $68 million in grants to develop two types of national data infrastructure, one aimed at clinical data research networks and the other at patient-powered research networks, that together can help researchers across all spectrums of health care develop robust comparative health care data.

You may also be interested in...



PCORI Approves Drug-Focused Research Grants, Topic For First PCORnet Study

Patient-Centered Outcomes Research Institute board approves a plan for comparative-effectiveness research in a newly formed electronic data network as well as a number of studies tackling drug-related issues.

Big Data Poised To Change Pharma R&D, McKinsey Suggests

A McKinsey & Company white paper highlights the potential for big data gathered from across the health care spectrum to revolutionize pharma R&D.

PatientsLikeMe Developing Platform To Validate Patient-Reported Outcomes

While the primary objective will be to help members of the online patient community better manage their health, the new platform will offer an opportunity for pharmaceutical companies to validate patient-reported outcomes that they develop, something that could be useful as PROs gain more traction in the FDA review process.

Related Content

Topics

UsernamePublicRestriction

Register

MT142578

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel